The life science industry in Denmark has developed into one of the strongest clusters in Europe. With excellent interplay between public and private partners and a unique test environment, Denmark turns clinical research into business. For many years, Denmark has constituted an international health laboratory, attracting international businesses and researchers.
Reasons include the presence of several different types of healthcare industries, a long-standing tradition for efficient public-private partnerships, plus a keen political focus on creating framework conditions conducive to research and business development in healthcare and welfare.
A new analysis from the Confederation of Danish Industry shows a very positive development in international sales for Danish life science companies. In 2015, the export reached a significant milestone, as international sales increased to more than DKK 100 billion equivalent to €13.7 billion ($15.4 billion). The milestone is the result of a period of great success and growth in the Danish life science sector. From 2000 to 2015, the export of medicines and medical devices increased from €4.5 billion ($5 billion) to €13.7 billion ($15.4 billion).
Over the past five decades, the Indian life sciences sector has witnessed exponential growth both in terms of broadening of scope and deepening of capabilities across the industry value chain. One of the key challenges the sector faces is the need for a strong collaboration between life science and healthcare companies not just on products but also on solutions to help meet the demand-supply mismatch. The need of the hour is for the product-push models to be complemented with service-oriented models that place a high priority on patients’ interests.
The past twenty years have seen tremendous changes in the life science sector in India. New initiatives have helped to build basic science, establish laboratories, set up funding and recruitment programmes for postdoctoral researchers and faculty. India’s challenge now is to improve the flow of funds, to retain or bring back their best brains and to become more competitive internationally.